Resumen

FERIA DIAZ, Gisela Eduarda et al. Dyslipidemia in insulin resistance states. ccm [online]. 2019, vol.23, n.4, pp. 1347-1373.  Epub 01-Dic-2019. ISSN 1560-4381.

Dyslipidemia associated with insulin resistance is a common condition that increases the risk of atherosclerosis and diabetes mellitus. This bibliographic review describes the prevalence, categories and etiology of dyslipidemias; also the main alterations that occur in lipoproteins and their impact in blood lipid concentrations as well as the relationship between liver steatosis and inflammation. Finally, the therapeutic procedure for dyslipidemias is described through lifestyle modifications (hypocaloric diets, physical exercises, smoking cessation, reduction of alcohol consumption) and the use of lipidemia reducing medications such as statins, ezetimibe, fibrates, monoclonal antibodies, bile acid sequestrants, niacin and omega-3 fatty acids.

Palabras clave : dyslipidemia; insulin resistance; metabolic syndrome; diabetes mellitus; inflammation; risk factors.

        · resumen en Español     · texto en Español     · Español ( pdf )